Myocarditis

Myocarditis is an inflammatory disease of the heart muscle (myocardium) that can occur as a result of infections, autoimmune processes, toxic effects and other factors. This disease is characterized by damage to the myocardium and its dysfunction, which can lead to various clinical manifestations, including heart failure, arrhythmia and, in some cases, cardiogenic shock and sudden death. Diagnosis of myocarditis can be difficult, since its symptoms often resemble those of other cardiovascular diseases. The disease requires a thorough approach to diagnosis and treatment, since the course of myocarditis can vary from mild to severe.

History of the disease and interesting historical facts

The history of myocarditis has a long and interesting tradition in medical research. The first descriptions of inflammatory diseases of the heart can be found in the works of Hippocrates, who mentioned symptoms similar to the current understanding of myocarditis. In the 19th century, as a deeper understanding of the anatomy and physiology of the heart was established, researchers began to associate inflammatory processes in the body with myocardial diseases. In the early 20th century, with the discovery of microbiology and virology, it was established that some infectious agents, such as viruses, can cause myocarditis. Since then, thanks to advances in clinical medicine, myocarditis has become the subject of a full ceiling of research, including its genesis, pathogenesis, and therapy.

Epidemiology

Epidemiological studies show that myocarditis is relatively rare, but its true incidence may be significantly higher than expected due to the variety of clinical manifestations and difficulties in diagnosis. According to various population studies, the prevalence of myocarditis ranges from 1 to 10 cases per 100,000 people per year. The disease is more common in men than in women, and is most often detected in people aged 20 to 50 years. There is also some evidence confirming an increase in the incidence of the disease in connection with various pandemic infections, such as COVID-19.

Genetic predisposition to this disease

Genetic predisposition to myocarditis is still under active investigation. Some studies suggest that certain genetic markers may be associated with an increased risk of myocarditis. For example, changes in genes associated with the immune response (such as HLA genotypes) may promote autoimmune reactions that damage the myocardium. Other studies have found an association with polymorphisms in genes associated with inflammatory processes, such as TNF-α and IL-6. However, despite the identified genetic markers, many cases of myocarditis remain idiopathic and require further research to fully assess the role of heredity.

Risk factors for the development of this disease

Myocarditis can develop under the influence of various risk factors. These include:

• Infectious agents such as viruses (eg, Coxsackie virus, adenoviruses, influenza viruses) and bacteria (eg, streptococci).
• Autoimmune reaction processes that can occur as a result of diseases such as systemic lupus erythematosus, vasculitis.
• Toxic influences, including alcohol abuse and certain medications such as chemotherapy drugs.
• Presence of previous cardiovascular diseases.
• Stress factors and high physical activity can initiate the inflammatory process.

Diagnosis of this disease

Diagnosis of myocarditis begins with a clinical examination, where attention is paid to the main symptoms, such as shortness of breath, chest pain, arrhythmia and general weakness. The key tools for diagnosis are:

• Laboratory tests, including a complete blood count, which may show signs of inflammation (elevated CRP levels, leukocytosis).
• Echocardiography to assess heart function and detect possible myocardial damage.
• Electrocardiogram (ECG) to detect changes in rhythm and conduction.
• Contrast-enhanced magnetic resonance imaging (CEMRI), which can help visualize inflammatory changes.
• Myocardial biopsy, which is the “gold standard” for final verification of the diagnosis.

Particular attention should be paid to the differential diagnosis, excluding other conditions such as coronary heart disease, pericarditis and other forms of cardiomyopathy.

Treatment

Treatment of myocarditis requires a comprehensive approach and may include several areas:

• General treatment consists of providing rest to the patient, reducing physical activity and monitoring the condition.
• Pharmacological treatment includes the use of anti-inflammatory drugs, immunosuppressive drugs (eg, corticosteroids), and β-blockers to correct heart failure and control arrhythmias.
• Surgical treatment may be required in extreme cases, such as the use of pacemakers in cases of severe heart failure.
• Other treatments include physical therapy, cardiac resynthesis, and post-chemotherapy rehabilitation.

List of medications used to treat this disease

The main drugs used to treat myocarditis include:

• Corticosteroids (prednisolone, methylprednisolone);
• Neurophototherapy.
• ACE inhibitors (enalapril, lisinopril).
• β-blockers (metoprolol, carvedilol).
• Diuretics (furosemide).
• Antibiotics if there is a bacterial infection.

Disease monitoring

Monitoring the condition of a patient with myocarditis includes periodic examinations and control stages to assess the condition of the cardiovascular system. The main elements of monitoring are:

• Regular ECG and echocardiographic studies to monitor changes in heart function.
• Laboratory tests to monitor levels of inflammatory markers.
• Assessing the prognosis and possible complications such as pericarditis or heart failure.

The prognosis for myocarditis can vary: in most cases it is favorable if medical help is sought in a timely manner, but there is a risk of developing chronic cardiovascular diseases.

Age-related features of the disease

Myocarditis may present differently depending on the patient's age group. In children, symptoms may include fever and general weakness, which often leads to misinterpretation of the condition. In adults, myocarditis is more often accompanied by typical clinical symptoms, such as shortness of breath and chest pain. In older people, the disease may have less pronounced symptoms, which makes diagnosis difficult. In addition, they are at higher risk of developing complications due to concomitant chronic diseases.

Questions and Answers

• What is myocarditis? Myocarditis is an inflammatory disease of the heart muscle that can be caused by infections, autoimmune processes and toxic factors, leading to disturbances in the functioning of the heart.
• What are the main symptoms of myocarditis? The main symptoms include mental fatigue, shortness of breath, chest pain, arrhythmia and general malaise.
• What diagnostic methods are used to detect myocarditis? Clinical examination, laboratory tests, ECG, echocardiography and myocardial biopsy are used for diagnosis.
• How is myocarditis treated? Treatment includes rest, anti-inflammatory drugs, beta-blockers, and in some cases surgery.
• What is the prognosis for myocarditis? The prognosis varies; most patients recover with prompt diagnosis and treatment, but there is a risk of chronic heart failure.